Long interspersed element-1 protein expression is a hallmark of many human cancers

American Journal of Pathology

Volumn 184, Issue 5, 2014, Pages 1280-1286

  Rodić, Nemanja ^a   Sharma, Reema ^b   Sharma, Rajni ^a   Zampella, John ^a   Dai, Lixin ^a   Taylor, Martin S ^a   Hruban, Ralph H ^a,c   Iacobuzio Donahue, Christine A ^a,c   Maitra, Anirban ^a,c   Torbenson, Michael S ^a,c   Goggins, Michael ^a,c   Shih, Ie Ming ^a   Duffield, Amy S ^a   Montgomery, Elizabeth A ^a   Gabrielson, Edward ^a   Netto, George J ^a   Lotan, Tamara L ^a   De Marzo, Angelo M ^a   Westra, William ^a   Binder, Zev A ^a   Orr, Brent A ^d   Gallia, Gary L ^a   Eberhart, Charles G ^a   Boeke, Jef D ^a   Harris, Chris R ^e,f   Burns, Kathleen H ^a   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG INTERSPERSED ELEMENT 1 PROTEIN; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG; DEOXYRIBONUCLEASE I; LINE-1 ENDONUCLEASE, HUMAN;

ARTICLE; ASTROCYTOMA; BILE DUCT CARCINOMA; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER STAGING; CARCINOGENESIS; COLON CANCER; ENDOMETRIUM CARCINOMA; ESOPHAGUS CARCINOMA; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; LUNG CARCINOMA; NEOPLASM; OPEN READING FRAME; OVARY CARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROPOSON; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING; DEFICIENCY; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; DEOXYRIBONUCLEASE I; HUMANS; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84899548825     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.01.007     Document Type: Article

References (33)

1. A.P. Feinberg, and B. Vogelstein Hypomethylation distinguishes genes of some human cancers from their normal counterparts Nature 301 1983 89 92
2. D.T. Ting, D. Lipson, S. Paul, B.W. Brannigan, S. Akhavanfard, E.J. Coffman, G. Contino, V. Deshpande, A.J. Iafrate, S. Letovsky, M.N. Rivera, N. Bardeesy, S. Maheswaran, and D.A. Haber Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers Science 331 2011 593 596
3. K.H. Burns, and J.D. Boeke Human transposon tectonics Cell 149 2012 740 752
4. E. Lee, R. Iskow, L. Yang, O. Gokcumen, P. Hanseley, L.J. Luquette, J.G. Lohr, C.C. Harris, L. Ding, R.K. Wilson, D.A. Wheeler, R.A. Gibbs, R. Kucherlapati, C. Lee, P.V. Kharchenko, P.J. Park Network TCGAR Landscape of somatic retrotransposition in human cancers Science 337 2012 967 971
5. S. Solyom, A.D. Ewing, E.P. Rahrmann, T. Doucet, H.H. Nelson, M.B. Burns, R.S. Harris, D.F. Sigmon, A. Casella, B. Erlanger, S. Wheelan, K.R. Upton, R. Shukla, G.J. Faulkner, D.A. Largaespada, and H.H. Kazazian Jr. Extensive somatic L1 retrotransposition in colorectal tumors Genome Res 22 2012 2328 2338
6. C.R. Harris, R. Normart, Q. Yang, E. Stevenson, B.G. Haffty, S. Ganesan, C. Cordon-Cardo, A.J. Levine, and L.H. Tang Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes Genes Cancer 1 2010 115 124
7. B. Fu, S. Yachida, R. Morgan, Y. Zhong, E.A. Montgomery, and C.A. Iacobuzio-Donahue Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon Am J Clin Pathol 138 2012 356 366
8. R. Vang, K. Visvanathan, A. Gross, E. Maambo, M. Gupta, E. Kuhn, R.F. Li, B.M. Ronnett, J.D. Seidman, A. Yemelyanova, Ie M. Shih, P.A. Shaw, R.A. Soslow, and R.J. Kurman Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma Int J Gynecol Pathol 31 2012 243 253
9. S. Ergün, C. Buschmann, J. Heukeshoven, K. Dammann, F. Schnieders, H. Lauke, F. Chalajour, N. Kilic, W.H. Strätling, and G.G. Schumann Cell type-specific expression of LINE-1 open reading frames 1 and 2 in fetal and adult human tissues J Biol Chem 279 2004 27753 27763
10. G.L. Bratthauer, and T.G. Fanning Active LINE-1 retrotransposons in human testicular cancer Oncogene 7 1992 507 510
11. D. Bell, A. Berchuck, M. Birrer, J. Chien, D. Cramer, F. Dao, R. Dhir, P. DiSaia, H. Gabra, P. Glenn, A. Godwin, J. Gross, L. Hartmann, M. Huang, D. Huntsman, M. Iacocca, M. Imielinski, S. Kalloger, B. Karlan, D. Levine, G. Mills, C. Morrison, D. Mutch, N. Olvera, S. Orsulic, K. Park, N. Petrelli, B. Rabeno, J. Rader, B. Sikic, K. Smith-McCune, A. Sood, D. Bowtell, R. Penny, J. Testa, K. Chang Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
12. Hruban R, Iacobuzio-Donahue C: The pancreas. Robbins and Cotran Pathologic Basis of Disease, Professional Edition, ch 19. Philadelphia, Elsevier Inc, 2010, pp 901.
13. Elleson L, Pirog E: The female genital tract. Robbins and Cotran Pathologic Basis of Disease, Professional Edition, ch 22. Philadelphia, Elsevier Inc, 2010, pp 1032.
14. S.A. Khan, H.C. Thomas, M.B. Toledano, I.J. Cox, and S.D. Taylor-Robinson p53 Mutations in human cholangiocarcinoma: a review Liver Int 25 2005 704 716
15. K. Edlund, O. Larsson, A. Ameur, I. Bunikis, U. Gyllensten, B. Leroy, M. Sundström, P. Micke, J. Botling, and T. Soussi Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors Proc Natl Acad Sci U S A 109 2012 9551 9556
16. C. Girgin, H. Tarhan, M. Hekimgil, A. Sezer, and G. Gürel P53 mutations and other prognostic factors of renal cell carcinoma Urol Int 66 2001 78 83
17. H. Ohgaki, and P. Kleihues Genetic pathways to primary and secondary glioblastoma Am J Pathol 170 2007 1445 1453
18. A.Q. van Hoesel, C.J. van de Velde, P.J. Kuppen, G.J. Liefers, H. Putter, Y. Sato, D.A. Elashoff, R.R. Turner, J.M. Shamonki, E.M. de Kruijf, J.G. van Nes, A.E. Giuliano, and D.S. Hoon Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study Breast Cancer Res Treat 134 2012 1103 1114
19. E. Sunami, M. de Maat, A. Vu, R.R. Turner, and D.S. Hoon LINE-1 hypomethylation during primary colon cancer progression PLoS One 6 2011 e18884
20. E.J. Formeister, M. Tsuchiya, H. Fujii, S. Shpyleva, I.P. Pogribny, and I. Rusyn Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma Mutat Res 692 2010 26 33
21. N.Y. Cho, B.H. Kim, M. Choi, E.J. Yoo, K.C. Moon, Y.M. Cho, D. Kim, and G.H. Kang Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features J Pathol 211 2007 269 277
22. R.C. Iskow, M.T. McCabe, R.E. Mills, S. Torene, W.S. Pittard, A.F. Neuwald, E.G. Van Meir, P.M. Vertino, and S.E. Devine Natural mutagenesis of human genomes by endogenous retrotransposons Cell 141 2010 1253 1261
23. R. Shukla, K.R. Upton, M. Munoz-Lopez, D.J. Gerhardt, M.E. Fisher, T. Nguyen, P.M. Brennan, J.K. Baillie, A. Collino, S. Ghisletti, S. Sinha, F. Iannelli, E. Radaelli, A. Dos Santos, D. Rapoud, C. Guettier, D. Samuel, G. Natoli, P. Carninci, F.D. Ciccarelli, J.L. Garcia-Perez, J. Faivre, and G.J. Faulkner Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma Cell 153 2013 101 111
24. S.M. Belgnaoui, R.G. Gosden, O.J. Semmes, and A. Haoudi Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells Cancer Cell Int 6 2006 13
25. L. Chen, J.E. Dahlstrom, A. Chandra, P. Board, and D. Rangasamy Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer Breast Cancer Res Treat 136 2012 129 142
26. A. Matsunoki, K. Kawakami, M. Kotake, M. Kaneko, H. Kitamura, A. Ooi, G. Watanabe, and T. Minamoto LINE-1 methylation shows little intra-patient heterogeneity in primary and synchronous metastatic colorectal cancer BMC Cancer 12 2012 574
27. T. Morikawa, A. Kuchiba, X. Liao, Y. Imamura, M. Yamauchi, Z.R. Qian, R. Nishihara, K. Sato, J.A. Meyerhardt, C.S. Fuchs, and S. Ogino Tumor TP53 expression status, body mass index and prognosis in colorectal cancer Int J Cancer 131 2012 1169 1178
28. C.R. Harris, A. Dewan, A. Zupnick, R. Normart, A. Gabriel, C. Prives, A.J. Levine, and J. Hoh p53 Responsive elements in human retrotransposons Oncogene 28 2009 3857 3865
29. N.A. Wallace, V.P. Belancio, and P.L. Deininger L1 mobile element expression causes multiple types of toxicity Gene 419 2008 75 81
30. S.L. Gasior, T.P. Wakeman, B. Xu, and P.L. Deininger The human LINE-1 retrotransposon creates DNA double-strand breaks J Mol Biol 357 2006 1383 1393
31. N.G. Coufal, J.L. Garcia-Perez, G.E. Peng, M.C. Marchetto, A.R. Muotri, Y. Mu, C.T. Carson, A. Macia, J.V. Moran, and F.H. Gage Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells Proc Natl Acad Sci U S A 108 2011 20382 20387
32. A. Haoudi, O.J. Semmes, J.M. Mason, and R.E. Cannon Retrotransposition- competent human LINE-1 induces apoptosis in cancer cells with intact p53 J Biomed Biotechnol 2004 2004 185 194
33. K.I. Leonova, L. Brodsky, B. Lipchick, M. Pal, L. Novototskaya, A.A. Chenchik, G.C. Sen, E.A. Komarova, and A.V. Gudkov p53 Cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs Proc Natl Acad Sci U S A 110 2013 E89 E98